RELIV INTERNATIONAL INC

2020 Q2 Form 10-Q Financial Statement

#000143774920010918 Filed on May 15, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.731M $2.829M $2.381M
YoY Change 42.32% 18.8% -35.3%
Cash & Equivalents $2.731M $2.829M $2.381M
Short-Term Investments
Other Short-Term Assets $605.8K $663.5K $693.8K
YoY Change -18.14% -4.35% 0.54%
Inventory $3.028M $2.810M $2.264M
Prepaid Expenses
Receivables $279.9K $215.0K $246.0K
Other Receivables $1.139M $1.337M $1.290M
Total Short-Term Assets $7.783M $7.854M $6.875M
YoY Change 16.94% 14.24% -22.27%
LONG-TERM ASSETS
Property, Plant & Equipment $4.281M $4.359M $4.649M
YoY Change -6.3% -6.24% -16.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $505.0K $505.0K $505.0K
YoY Change 0.0% 0.0%
Other Assets $388.7K
YoY Change 13.23%
Total Long-Term Assets $9.075M $9.187M $10.73M
YoY Change -10.56% -14.35% -14.03%
TOTAL ASSETS
Total Short-Term Assets $7.783M $7.854M $6.875M
Total Long-Term Assets $9.075M $9.187M $10.73M
Total Assets $16.86M $17.04M $17.60M
YoY Change 0.33% -3.18% -17.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.820M $2.155M $2.171M
YoY Change -5.13% -0.74% 2.91%
Accrued Expenses $1.553M $1.977M $1.526M
YoY Change 4.65% 29.59% 163.06%
Deferred Revenue $317.6K $330.8K $365.4K
YoY Change -10.99% -9.49% -0.58%
Short-Term Debt $500.0K $500.0K $500.0K
YoY Change 0.0% 0.0% 0.0%
Long-Term Debt Due $833.6K
YoY Change
Total Short-Term Liabilities $4.575M $5.124M $4.828M
YoY Change 3.12% 6.15% -31.73%
LONG-TERM LIABILITIES
Long-Term Debt $528.4K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $140.5K $115.5K $483.8K
YoY Change -72.32% -76.13% 5.47%
Total Long-Term Liabilities $771.1K $192.1K $642.5K
YoY Change 23.04% -70.1% 40.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.575M $5.124M $4.828M
Total Long-Term Liabilities $771.1K $192.1K $642.5K
Total Liabilities $5.346M $5.317M $5.470M
YoY Change 5.58% -2.81% -27.36%
SHAREHOLDERS EQUITY
Retained Earnings -$12.29M -$12.09M -$11.69M
YoY Change 1.79% 3.47% 12.3%
Common Stock $30.65M $30.65M $30.63M
YoY Change 0.03% 0.05% 0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.851M $5.851M $5.851M
YoY Change 0.0% 0.0% 9.61%
Treasury Stock Shares
Shareholders Equity $11.51M $11.72M $12.13M
YoY Change
Total Liabilities & Shareholders Equity $16.86M $17.04M $17.60M
YoY Change 0.33% -3.18% -17.45%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000768710
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1746499
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
RELIV INTERNATIONAL INC
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001
CY2020Q1 dei Trading Symbol
TradingSymbol
relv
CY2020Q1 relv Accounts Payable And Accrued Liabilities Current Excluding Income Taxes Payable
AccountsPayableAndAccruedLiabilitiesCurrentExcludingIncomeTaxesPayable
3954076
CY2019Q4 relv Accounts Payable And Accrued Liabilities Current Excluding Income Taxes Payable
AccountsPayableAndAccruedLiabilitiesCurrentExcludingIncomeTaxesPayable
2808948
CY2020Q1 relv Computer Equipment And Software Gross
ComputerEquipmentAndSoftwareGross
2197639
CY2019Q4 relv Computer Equipment And Software Gross
ComputerEquipmentAndSoftwareGross
2240063
CY2020Q1 relv Contract With Customer Returns As Percent Of Net Sales
ContractWithCustomerReturnsAsPercentOfNetSales
0.0004
CY2019Q1 relv Contract With Customer Returns As Percent Of Net Sales
ContractWithCustomerReturnsAsPercentOfNetSales
0.0004
CY2020Q1 relv Estimated Tax Benefit Nol Carryback
EstimatedTaxBenefitNolCarryback
225000
CY2020Q1 relv Increase Decrease In Accounts Receivable And Due From Related Parties And Distibutors
IncreaseDecreaseInAccountsReceivableAndDueFromRelatedPartiesAndDistibutors
104389
CY2019Q1 relv Increase Decrease In Accounts Receivable And Due From Related Parties And Distibutors
IncreaseDecreaseInAccountsReceivableAndDueFromRelatedPartiesAndDistibutors
839989
CY2020Q1 relv Inventory Sales Aids And Promotional Materials Net Of Reserves
InventorySalesAidsAndPromotionalMaterialsNetOfReserves
102830
CY2019Q4 relv Inventory Sales Aids And Promotional Materials Net Of Reserves
InventorySalesAidsAndPromotionalMaterialsNetOfReserves
120811
CY2019Q1 relv Treasury Stock Value Other
TreasuryStockValueOther
27281
CY2020Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2155345
CY2019Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1565198
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
215045
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
107369
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
161113
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-937320
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30643771
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30643771
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5306
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
121177
CY2020Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1210104
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
891492
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10119806
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10086560
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-976931
CY2020Q1 us-gaap Assets
Assets
17040882
CY2019Q4 us-gaap Assets
Assets
15306996
CY2020Q1 us-gaap Assets Current
AssetsCurrent
7853798
CY2019Q4 us-gaap Assets Current
AssetsCurrent
5865518
CY2020Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
10145645
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
10145005
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2828639
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1630779
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1989974
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2381087
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1197860
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
391113
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2110013
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2110013
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1746449
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1746449
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2110
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2110
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
622725
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
645855
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentrations of Risk</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Effective <div style="display: inline; font-style: italic; font: inherit;"> January 1, 2019, </div>we have entered into outsourcing agreements with Nutracom LLC (&#x201c;Nutracom&#x201d;) to manufacture our nutritional and dietary supplements and for warehousing and fulfillment services for the U.S. distribution of our products. Nutracom has also issued promissory notes to us for the acquisition of our manufacturing and fulfillment operations. Any inability of Nutracom to deliver these contracted services or to repay the promissory notes could adversely impact our future operating results and valuation of our Nutracom equity investment. See Note <div style="display: inline; font-style: italic; font: inherit;">2</div> and Note <div style="display: inline; font-style: italic; font: inherit;">3</div> for further discussion of our relationship with Nutracom.</div></div></div></div></div></div>
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
330763
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
322261
CY2020Q1 us-gaap Cost Method Investments
CostMethodInvestments
505000
CY2019Q4 us-gaap Cost Method Investments
CostMethodInvestments
505000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2654843
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2433732
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
9760980
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
9290831
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
143789
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
144893
CY2020Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1091247
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1099228
CY2020Q1 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
2390930
CY2019Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
2418921
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1665782
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.38
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.36
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-86272
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7058
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.368
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.071
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
320718
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
212716
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1722277
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-87162
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-5925
CY2020Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1230768
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1237142
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
434549
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
484336
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
671644
CY2019Q4 us-gaap Inventory Net
InventoryNet
2701688
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
208666
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-178000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
245503
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
22406
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1209504
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19235
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
40411
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
42522
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
223097
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1918
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
189667
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-705371
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
49681
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
364638
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
251056
CY2020Q1 us-gaap Interest Expense
InterestExpense
6105
CY2019Q1 us-gaap Interest Expense
InterestExpense
5412
CY2020Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
38346
CY2019Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
47843
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2498333
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2275306
CY2020Q1 us-gaap Inventory Net
InventoryNet
2809829
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
305571
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
39662
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
49262
CY2020Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
905190
CY2019Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
905190
CY2019Q1 us-gaap Lessor Operating Lease Renewal Term
LessorOperatingLeaseRenewalTerm
P5Y
CY2019Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P7Y
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17040882
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15306996
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5124415
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3989157
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
192099
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
216196
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
500000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
22721
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10801
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1261411
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126746
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
662336
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
623644
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
6
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
521685
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
198673
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
178463
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
236771
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76648
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103580
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
265936
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
354440
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-39611
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
22211
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
115451
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
112616
CY2020Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
CY2019Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
24618
CY2020Q1 us-gaap Other Noncash Income
OtherNoncashIncome
CY2019Q1 us-gaap Other Noncash Income
OtherNoncashIncome
86433
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-70906
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5428
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9207
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38890
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
663535
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
304048
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
31928
CY2019Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
49691
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
500000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14479242
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14527400
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4359436
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4440840
CY2020Q1 us-gaap Purchase Obligation
PurchaseObligation
1010000
CY2020Q1 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
175753
CY2019Q1 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
158566
CY2020Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
159984
CY2019Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
151102
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12093159
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12755495
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10282665
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9489504
CY2020Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
267909
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
139542
CY2020Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
3328455
CY2019Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
3117572
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3777682
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3739527
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5306
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11724368
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11101643
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
11992864
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12131162
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5851423
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5851423
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
540144
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Due to the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic, there has been uncertainty and disruption in the global economy and financial markets. We are <div style="display: inline; font-style: italic; font: inherit;">not</div> aware of any specific event or circumstance that would require updates to our estimates or judgments or require us to revise the carrying value of our assets or liabilities as of&nbsp;the date of issuance of this Quarterly Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q. These estimates <div style="display: inline; font-style: italic; font: inherit;"> may </div>change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under unanticipated conditions or assumptions.</div></div></div></div></div></div>
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1746000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1746000

Files In Submission

Name View Source Status
0001437749-20-010918-index-headers.html Edgar Link pending
0001437749-20-010918-index.html Edgar Link pending
0001437749-20-010918.txt Edgar Link pending
0001437749-20-010918-xbrl.zip Edgar Link pending
ex_185801.htm Edgar Link pending
ex_185802.htm Edgar Link pending
ex_185803.htm Edgar Link pending
ex_185804.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
image02.jpg Edgar Link pending
image03.jpg Edgar Link pending
image04.jpg Edgar Link pending
image05.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
relv-20200331.xml Edgar Link completed
relv-20200331.xsd Edgar Link pending
relv-20200331_cal.xml Edgar Link unprocessable
relv-20200331_def.xml Edgar Link unprocessable
relv-20200331_lab.xml Edgar Link unprocessable
relv-20200331_pre.xml Edgar Link unprocessable
relv20200331_10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending